FGA
PJP icon

Fortis Group Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Fortis Group Advisors’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4K Hold
100
– – ﹤0.01% 379
2025
Q4 		$10.5K Hold
100
– – ﹤0.01% 380
2025
Q3 		$9.25K Hold
100
– – ﹤0.01% 346
2025
Q2 		$7.99K Hold
100
– – ﹤0.01% 347
2025
Q1 		$8.66K Hold
100
– – ﹤0.01% 312
2024
Q4 		$8.26K Hold
100
– – ﹤0.01% 324
2024
Q3 		$8.7K Hold
100
– – ﹤0.01% 308
2024
Q2 		$8.22K Sell
100
-25,938
-100% -$2.06M ﹤0.01% 309
2024
Q1 		$2.09M Buy
26,038
+25,838
+12,919% +$2M 0.38% 60
2023
Q4 		$15.2K Buy
200
+100
+100% +$7.15K ﹤0.01% 257
2023
Q3 		$7.24K Buy
+100
New +$7.67K ﹤0.01% 254
2020
Q3 		$6K Buy
+100
New +$6.54K ﹤0.01% 325

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fortis Group Advisors's PJP Position: Q1 2026 in Review

Fortis Group Advisors held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 100 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

Fortis Group Advisors first reported a position in PJP in Q3 2020 and has held it in 12 quarters since. The position peaked at $2.09M in Q1 2024. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Fortis Group Advisors held 100 shares of Invesco Pharmaceuticals ETF worth $10.4K as of Q1 2026.
  • Fortis Group Advisors left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Fortis Group Advisors's portfolio in Q1 2026, its #379 holding.
  • Fortis Group Advisors first reported a position in Invesco Pharmaceuticals ETF in Q3 2020 and has held it in 12 quarters since.
  • Fortis Group Advisors's Invesco Pharmaceuticals ETF position peaked at $2.09M in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Fortis Group Advisors's 13F filing for Q1 2026, filed 8 May 2026.